Anúncio
Anúncio
HCAT
Health Catalyst, Inc Common Stock
2.50
USDPatrocinado
+0.12
+4.83%
07 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
2.50
0.00
0.00%
Relatórios de Lucros HCAT
Rácio de surpresa positiva
HCAT separação 23 de 26 últimas estimativas.
88%
Próximo Relatório
Data do Próximo Relatório
24 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$75.56M
/$0.09
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-1.00%
/+50.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-5.09%
/+125.00%
Health Catalyst, Inc Common Stock earnings per share and revenue
On 10 de nov. de 2025, HCAT reported earnings of 0.06 USD per share (EPS) for Q3 25, missing the estimate of 0.06 USD, resulting in a -0.66% surprise. Revenue reached 76.32 milhão, compared to an expected 77.42 milhão, with a -1.41% difference. The market reacted with a -5.61% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analistas forecast an EPS of 0.09 USD, with revenue projected to reach 75.56 milhão USD, implying an aumentar of 50.00% EPS, and diminuir of -1.00% in Revenue from the last quarter.
FAQ
What were Health Catalyst, Inc Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Health Catalyst, Inc Common Stock reported EPS of $0.06, missing estimates by -0.66%, and revenue of $76.32M, -1.41% below expectations.
How did the market react to Health Catalyst, Inc Common Stock's Q3 2025 earnings?
The stock price moved down -5.61%, changed from $2.85 before the earnings release to $2.69 the day after.
When is Health Catalyst, Inc Common Stock expected to report next?
The next earning report is scheduled for 24 de fev. de 2026.
What are the forecasts for Health Catalyst, Inc Common Stock's next earnings report?
Based on 12
analistas, Health Catalyst, Inc Common Stock is expected to report EPS of $0.09 and revenue of $75.56M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio